Read + Share
Amedeo Smart
Independent Medical Education
Liu H, Yan R, Xiao Z, Huang X, et al. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling. Breast Cancer Res 2023;25:43.PMID: 37069669
Email
LinkedIn
Facebook
Twitter
Privacy Policy